GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (OISE:ALVO) » Definitions » Notes Receivable

Alvotech (OISE:ALVO) Notes Receivable : kr0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Notes Receivable?

Alvotech's Notes Receivable for the quarter that ended in Mar. 2024 was kr0 Mil.


Alvotech Notes Receivable Historical Data

The historical data trend for Alvotech's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Notes Receivable Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - - -

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alvotech Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Alvotech Notes Receivable Related Terms

Thank you for viewing the detailed overview of Alvotech's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (OISE:ALVO) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.